Literature DB >> 3496638

Determination of T lymphocyte subpopulations in patients with lung cancer. A comparison between lung lavage and peripheral blood by monoclonal antibodies and flow cytometry.

A Fracchia, M Pacetti, M Barberis, M A Mura, C Le Grazie, E Longhini.   

Abstract

In order to determine whether the alterations of immunoregulatory T cells described both in smokers and in patients with lung cancer occur in the deep lung as well as in peripheral blood, we analyzed T lymphocyte subpopulations in bronchoalveolar lavage (BAL) and in the blood of 12 patients with untreated lung cancer and of 8 controls. The immunocompetent cellular population of BAL fluid analyzed by differential cell count of alveolar macrophages, lymphocytes and neutrophils did not show considerable differences in the two groups studied. By contrast, the analysis of BAL T lymphocytes and their subsets showed significant alterations in patients compared with controls: a percentage increase of OKT3+ and OKT8+ lymphocytes and a decrease of the OKT4+/OKT8+ ratio was found in both the involved and uninvolved lung of patients. The immunologic pattern of T lymphocytes in blood did not show significant differences between patients and controls. Our data indicate that alterations in immunoregulatory T cells in lung cancer are more pronounced in BAL fluid obtained from both lungs than in peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496638     DOI: 10.1159/000195198

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

Review 1.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer.

Authors:  María Del Mar Valenzuela-Membrives; Francisco Perea-García; Abel Sanchez-Palencia; Francisco Ruiz-Cabello; Mercedes Gómez-Morales; María Teresa Miranda-León; Inmaculada Galindo-Angel; María Esther Fárez-Vidal
Journal:  Oncotarget       Date:  2016-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.